Top Patient Advocacy Orgs Have Industry Ties in Leadership, Study Shows
Three-quarters of the highest-revenue patient advocacy organizations (PAOs) in the U.S. have board members or senior leadership with ties to the pharmaceutical or medical device industry, a cross-sectional study showed. Of the 50 PAOs reviewed, 74% had board members with prior or current industry ties, and 50% had paid staff or executives with these ties, […]
Medication treatment of pediatric psychiatric disorders reduces the later onset of substance use problems: Early and longer-lasting treatment reduces risk of substance use disorder most significantly
One half of psychiatric and substance use disorders start by the age of 18; three-quarters by age 24. While these are concerning statistics, a new study from Massachusetts General Hospital (MGH) finds that treating psychiatric disorders with psychotropic medications in children and adolescents does not increase the risk of developing substance use, misuse, or substance […]